Anticoccidial Drugs Market Analysis

Anticoccidial Drugs Market Size (2021 to 2030)

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.

Anticoccidial Drugs Market Share Insights

Based on the Drug type, the ionophore anticoccidials segment had the largest market share of the global anticoccidial drugs market in 2022. Based on animal type, the poultry animal segment had the largest market share of the global anticoccidial drugs market in 2022. The North American anticoccidial drugs market had the most significant global market share in 2022.

Impact of COVID-19 on the Global Anticoccidial Drugs Market

The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Coccidiosis is a viral disease caused by a single-cell parasite that can only be seen under a microscope. It affects the intestinal tracts of animals. Weight loss, moderate sporadic to extreme diarrhea, dehydration, and decreased breeding are all signs of coccidiosis, one of the most common parasitic diseases in domesticated animals.

Increasing clinical trials in developing medicines or vaccines for animals to prevent infections propels this market's growth rate to new heights. Anticoccidial drugs are used to treat coccidiosis in animals and can also be a part of the solution in combating COVID-19.

Market Dynamics

The global anticoccidial drugs market is primarily driven by the YOY growth in the prevalence of coccidiosis and increasing focus on animal health. In addition, factors such as the need to prevent the spread of diseases in animals with effective medication and the rise in the consumption rate of meat and poultry products are also contributing to the market growth. However, challenges such as the need for more skilled persons in manufacturing appropriate drugs and fluctuations in raw material prices may hamper market growth.

Segments and Related Analysis

Anticoccidial Drugs Market - By Drug Type

Antibiotic Anticoccidials: This segment is expected to witness significant growth due to research efforts introducing newer and more effective drugs.

Ionophore Anticoccidials: The ionophore segment had the largest market share in 2022, driven by advantages like improved efficacy and lower risk of drug resistance.

Chemical Derivative Anticoccidials: This segment plays a crucial role in providing alternative methods to combat coccidiosis.

Anticoccidial Drugs Market - By Animal Type

Poultry: The poultry animal segment led the market in 2022 and is expected to continue dominating, driven by the growing adoption of anticoccidial drugs.

Swine, Fish, Cattle: These segments cater to the specific needs of different animal groups, contributing to the overall market growth.

By Region Analysis

North America: The region accounted for the most significant market share in 2022, driven by advanced manufacturing techniques and adoption of companion animals.

Europe: The European market is expected to grow steadily due to the increasing meat consumption rate and sophisticated pet care industry.

Asia Pacific: APAC is forecasted to grow at a CAGR of 4.3% from 2022 to 2027, propelled by the growing pet population and demand for poultry products.

Latin America, Middle East, and Africa: These regions are expected to witness growth in the usage of anticoccidial drugs, driven by increasing awareness and demand for veterinary healthcare.

Key Market Players and Competitive Landscape

Noteworthy companies in the global anticoccidial drugs market include Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc. These players adopt various strategies to maximize their market share through product development, mergers, acquisitions, and partnerships.

Recent Developments in the Market

April 2022: Amlan International announced natural alternatives to anticoccidial drugs.

May 2020: Zoetis showcased significant weight gain in suckling calves from implants.

September 2019: Virbac launched Multimin for cattle.

October 2019: Ceva Sante Animale partnered with ProBioGen to transform poultry vaccines with proprietary technology.